News | April 05, 2021
Tatva Chintan Pharma Chem plans for IPO files DRHP with SEBI
TCPCL is the largest and only commercial manufacturer of SDAs for zeolites in India
TCPCL is the largest and only commercial manufacturer of SDAs for zeolites in India
FY26 revenue rises 17% to Rs. 5,453 crore as US generics business jumps 49% and adjusted EBITDA margin improves to 26% for the quarter
The company informed stock exchanges that the appellate authority has set aside the GST demand along with applicable interest and penalty
Company plans to appeal against CGST order related to alleged inadmissible input tax credit claims
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
The capacity addition to be implemented in a phased manner amid evolving business and market dynamics
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
This development signals a cleanup of Anlon’s borrowing profile and closure of legacy debt facilities
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
Subscribe To Our Newsletter & Stay Updated
